Neil W. Gibson, Chief Scientific Officer at Regulus Therapeutics Inc. ("RGLS"), sold 2,500 shares at $8.11 ($20K) on 2014-04-09, disclosed to the SEC on 2014-04-10.
Scheduled sale ($20k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGLS | SELL | 2014-12-01 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-31 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-24 | $48K | — | Filing → |